Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Amiodarone hydrochloride
hameln pharma Ltd
C01BD01
Amiodarone hydrochloride
50mg/1ml
Solution for injection
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 02030200; GTIN: 4260016650873
PACKAGE LEAFLET: INFORMATION FOR THE USER AMIODARONE HYDROCHLORIDE 50 MG/ML Concentrate for Solution for Injection/Infusion Active substance: Amiodarone hydrochloride HAMELN ----- ---------------------------------------------------------------------------------------------------------------- READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. → Keep this leaflet. You may need to read it again. → If you have any further questions, ask your doctor or pharmacist. → If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. HAMELN WHAT IS IN THIS LEAFLET: 1. What Amiodarone is and what it is used for 2. What you need to know before you are given Amiodarone 3. How Amiodarone is given 4. Possible side effects 5. How to store Amiodarone 6. Contents of the pack and other information 1. WHAT AMIODARONE IS AND WHAT IT IS USED FOR WHAT IS AMIODARONE USED FOR? Amiodarone is used to treat irregular beating of your heart called “arrhythmias”. Amiodarone works by controlling your heart if it is not beating normally. Amiodarone as a solution for injection is normally only given when a quick response is needed or if you are unable to take tablets. Your doctor will give you the injection and you will be monitored under hospital or specialist supervision. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN AMIODARONE DO NOT USE AMIODARONE: • if you are allergic (hypersensitive) to amiodarone, iodine or any of the other ingredients of this medicine (listed in section 6). • if you have a slower than usual heartbeat (called sinus bradycardia) or are suffering from an illness which causes irregular heartbeats (e.g. sino-atrial block, sick sinus syndrome). • if you have any other problems with your heart and do NOT have a pacemaker, for example if you have AV block (a type of heart conduction disorder). • if your thyroid gland is not working properly. Your doctor should test your t Read the complete document
OBJECT 1 AMIODARONE HYDROCHLORIDE 50 MG/ML CONCENTRATE FOR SOLUTION FOR INJECTION/INFUSION Summary of Product Characteristics Updated 21-Feb-2017 | hameln pharmaceuticals ltd 1. Name of the medicinal product Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion 2. Qualitative and quantitative composition 1 ml Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion contains 50 mg amiodarone hydrochloride equivalent to 46.9 mg amiodarone. Each ampoule with 3 ml of Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion contains 150 mg amiodarone hydrochloride. One ampoule of Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion diluted as recommended in 250 ml of 5 % w/v Glucose Intravenous Infusion results in a concentration of 0.6 mg/ml of amiodarone hydrochloride. Excipients: 1 ml Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion contains 22.2 mg of benzyl alcohol. Each ampoule with 3 ml contains 66.6 mg of benzyl alcohol. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Concentrate for Solution for Injection and Infusion. Clear pale yellow sterile solution practically free from particles, in a clear and colourless glass ampoule. pH: 3.5-4.5 4. Clinical particulars 4.1 Therapeutic indications Amiodarone hydrochloride is indicated for the treatment of serious cardiac arrhythmias, in cases where other therapies are not effective or contraindicated: - atrial arrhythmias, including atrial fibrillation or flutter - AV nodal arrhythmias and AV reentrant tachycardia, e.g. as a manifestation of Wolff-Parkinson-White syndrome - life-threatening ventricular arrhythmias, including persistent or non-persistent ventricular tachycardia or episodes of ventricular fibrillation Treatment should be initiated and normally monitored only under hospital or specialist supervision. Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion can be used Read the complete document